Chest CT Biomarkers as Prognostic Predictors in SSc-ILD

Enrolling by invitationOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

March 31, 2026

Conditions
Systemic Sclerosis
Interventions
DIAGNOSTIC_TEST

HRCT biomarkers

HRCT imaging biomarkers of airways, vessels, and overall extent of fibrosis

Trial Locations (7)

Unknown

Bichat-Claude Bernard hospital, Paris

Hanover Medical School, Hanover

Marche Polytechnic University, Ancona

Sassari University, Sassari

Siena University Hospital, Siena

Leeds Hospital/University of Leeds, Leeds

Royal Brompton Hospital, London

All Listed Sponsors
collaborator

Imperial College London

OTHER

collaborator

Royal Free and University College Medical School

OTHER

collaborator

The Leeds Teaching Hospitals NHS Trust

OTHER

collaborator

Hannover Medical School

OTHER

collaborator

University of Siena

OTHER

collaborator

Università Politecnica delle Marche

OTHER

collaborator

Azienda Ospedaliero Universitaria di Sassari

OTHER

collaborator

Bichat Hospital

OTHER

lead

Royal Brompton & Harefield NHS Foundation Trust

OTHER